… a view of acellular pertussis vaccine development," which we believe is not … vaccine-induced
protective immunity which are essential for the development of a safe and effective vaccine …

… for pertussis control as long ago as 1981, 6, 7 whereas in Sweden, Italy 8 and Germany (countries
that had largely abandoned pertussis vaccination … coping with endemic pertussis. …

… FHA does not confer additional protection to acellular pertussis … is no scientific basis for
including FHA in a pertussis vaccine. … best pertussis vaccine to our children as soon as possible. …

… , the importance of the birth dose was demonstrated in that children who received a first HBV
dose at birth were more likely to receive their first diphtheria, tetanus, and pertussis vaccine …

… response than the whole-cell vaccine, particularly against pertussis toxin. Once acquired, …
pertussis vaccine immunogenicity and a better correlate of long-term immunity to B pertussis …

… How often must we be reminded of the ancient precept "primum non nocere" ? … adverse
reactions associated with the use of Wellcome pertussis vaccine. He rightly draws attention to the …

… More importantly, the most efficacious DTaP vaccine is not … the immunization effort in this
and other countries. Our goal should be the eventual control of B pertussis infection and not just …

… ongoing pertussis vaccine efficacy trials will result in the introduction of an acellular … non
nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine…

… There were no serious reactions. With the pertussis vaccine there were slightly more local
reactions than with the DT toxoids alone, but the rates of postvaccination fever were the same. …

… The use of a monocomponent pertussis vaccine has been challenged because, as … non
nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine…